Emotional fronto-cingulate cortex activation and brain derived neurotrophic factor polymorphism in premenstrual dysphoric disorder

Human Brain Mapping

Volumn 35, Issue 9, 2014, Pages 4450-4458

  Comasco, Erika ^a   Hahn, Andreas ^b   Ganger, Sebastian ^b   Gingnell, Malin ^a   Bannbers, Elin ^a   Oreland, Lars ^a   Wikström, Johan ^a   Epperson, C Neill ^c   Lanzenberger, Rupert ^b   Sundström Poromaa, Inger ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

5 HTTLPR; Anterior cingulate cortex; BDNF Val66Met; Emotion; FMRI; Premenstrual dysphoric disorder

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, HUMAN;

BRAIN; BRAIN MAPPING; CINGULATE GYRUS; EMOTION; FEMALE; FOLLICULAR PHASE; FRONTAL LOBE; GENETICS; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; LUTEAL PHASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PREMENSTRUAL DYSPHORIC DISORDER; PSYCHOLOGY; SIGNAL PROCESSING; SINGLE NUCLEOTIDE POLYMORPHISM;

BRAIN; BRAIN MAPPING; BRAIN-DERIVED NEUROTROPHIC FACTOR; EMOTIONS; FEMALE; FOLLICULAR PHASE; FRONTAL LOBE; GENOTYPE; GENOTYPING TECHNIQUES; GYRUS CINGULI; HUMANS; LUTEAL PHASE; MAGNETIC RESONANCE IMAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PREMENSTRUAL DYSPHORIC DISORDER; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 84904468863     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22486     Document Type: Article

References (53)

1. Adams M, McCrone S (2012): SRD5A1 genotype frequency differences in women with mild versus severe premenstrual symptoms. Issues Ment Health Nurs 33:101-108.
2. APA (2013): Diagnostic and Statistical Manual of Mental Disorders, 5th ed. DSM-5. Washington DC: American Psychiatric Association.
3. Backstrom T, Bixo M, Johansson M, Nyberg S, Ossewaarde L, Ragagnin G, Savic I, Stromberg J, Timby E, van Broekhoven F, van Wingen G (2013): Allopregnanolone and mood disorders. Prog Neurobiol 2014;113:88-94.
4. Bath KG, Chuang J, Spencer-Segal JL, Amso D, Altemus M, McEwen BS, Lee FS (2012): Variant brain-derived neurotrophic factor (Valine66Methionine) polymorphism contributes to developmental and estrous stage-specific expression of anxiety-like behavior in female mice. Biol Psychiatry 72:499-504.
5. Cahill L (2006): Why sex matters for neuroscience. Nat Rev Neurosci 7:477-484.
6. Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, Herrera DG, Toth M, Yang C, McEwen BS, Hempstead BL, Lee FS (2006): Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314:140-143.
7. Dhingra V, Magnay JL, O'Brien PM, Chapman G, Fryer AA, Ismail KM (2007): Serotonin receptor 1A C(-1019)G polymorphism associated with premenstrual dysphoric disorder. Obstet Gynecol 110:788-792.
8. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR (2003): The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112: 257-269.
9. Epperson CN (2013): Premenstrual dysphoric disorder and the brain. Am J Psychiatry 170:248-252.
10. Epperson CN, Bale TL (2012): BDNF Val66Met polymorphism and brain-derived neurotrophic factor levels across the female life span: Implications for the sex bias in affective disorders. Biol Psychiatry 72:434-436.
11. Epperson CN, Haga K, Mason GF, Sellers E, Gueorguieva R, Zhang W, Weiss E, Rothman D, Krystal JH (2002): Cortical y-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: A 1H-MRS study. Arch Gen Psychiatry 59:851-858.
12. Epperson CN, Steiner M, Hartlage SA, Eriksson E, Schmidt PJ, Jones I, Yonkers KA (2012): Premenstrual dysphoric disorder: Evidence for a new category for DSM-5. Am J Psychiatry 169:465-475.
13. Etkin A, Schatzberg AF (2011): Common abnormalities and disorder-specific compensation during implicit regulation of emotional processing in generalized anxiety and major depressive disorders. Am J Psychiatry 168:968-978.
14. Etkin A, Egner T, Kalisch R (2011): Emotional processing in anterior cingulate and medial prefrontal cortex. Trends Cogn Sci 15:85-93.
15. Freeman EW, Rickels K, Sondheimer SJ, Polansky M (1999): Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: A randomized controlled trial. Arch Gen Psychiatry 56:932-939.
16. Galanopoulou AS (2008): Sexually dimorphic expression of KCC2 and GABA function. Epilepsy Res 80:99-113.
17. Gibbs RB (1999): Treatment with estrogen and progesterone affects relative levels of brain-derived neurotrophic factor mRNA and protein in different regions of the adult rat brain. Brain Res 844:20-27.
18. Gillies GE, McArthur S (2010): Estrogen actions in the brain and the basis for differential action in men and women: A case for sex-specific medicines. Pharmacol Rev 62:155-198.
19. Gingnell M, Comasco E, Oreland L, Fredrikson M, Sundstrom-Poromaa I (2010): Neuroticism-related personality traits are related to symptom severity in patients with premenstrual dysphoric disorder and to the serotonin transporter gene-linked polymorphism 5-HTTPLPR. Arch Womens Ment Health 13:417-423.
20. Gingnell M, Morell A, Bannbers E, Wikstrom J, Sundstrom Poromaa I (2012): Menstrual cycle effects on amygdala reactivity to emotional stimulation in premenstrual dysphoric disorder. Horm Behav 62:400-406.
21. Hammarbäck S, Bäckström T, MacGibbon-Taylor B (1989): Diagnosis of premenstrual tension syndrome: Description and evaluation of a procedure for diagnosis and differential diagnosis. J Psychosom Obstet Gynaecol 10:25-42.
22. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, Egan MF, Weinberger DR (2002): Serotonin transporter genetic variation and the response of the human amygdala. Science 297:400-403.
23. Hodgues WF, Spielberger CD (1969): An indicant of trait or state anxiety? J Consult Clin Psychol 33:430-434.
24. Huo L, Straub RE, Roca C, Schmidt PJ, Shi K, Vakkalanka R, Weinberger DR, Rubinow DR (2007): Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene. Biol Psychiatry 62:925-933.
25. Jovanovic H, Cerin A, Karlsson P, Lundberg J, Halldin C, Nordstrom AL (2006): A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria. Psychiatry Res 148:185-193.
26. Kendler KS, Karkowski LM, Corey LA, Neale MC (1998): Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression. Am J Psychiatry 155:1234-1240.
27. Lang UE, Hellweg R, Gallinat J (2004): BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology 29:795-798.
28. Lang UE, Hellweg R, Sander T, Gallinat J (2009): The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations. Mol Psychiatry 14:120-122.
29. Lindquist KA, Wager TD, Kober H, Bliss-Moreau E, Barrett LF (2012): The brain basis of emotion: A meta-analytic review. Behav Brain Sci 35:121-143.
30. Martinowich K, Lu B (2008): Interaction between BDNF and serotonin: Role in mood disorders. Neuropsychopharmacology 33:73-83.
31. Martinowich K, Manji H, Lu B (2007): New insights into BDNF function in depression and anxiety. Nat Neurosci 10:1089-1093.
32. McNamara JO, Scharfman HE (2012): Temporal lobe epilepsy and the BDNF receptor, TrkB. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper's Basic Mechanisms of the Epilepsies [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US).
33. Montgomery SA, Asberg M (1979): A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389.
34. Nakamura NH, Rosell DR, Akama KT, McEwen BS (2004): Estrogen and ovariectomy regulate mRNA and protein of glutamic acid decarboxylases and cation-chloride cotransporters in the adult rat hippocampus. Neuroendocrinology 80:308-323.
35. Outhred T, Das P, Dobson-Stone C, Griffiths K, Felmingham KL, Bryant RA, Malhi G, Kemp AH (2012): The functional epistasis of 5-HTTLPR and BDNF Val66Met on emotion processing: A preliminary study. Brain Behav 2:778-788.
36. Ozan E, Okur H, Eker C, Eker OD, Gonul AS, Akarsu N (2010): The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels. Brain Res Bull 81:61-65.
37. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR (2005): 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: A genetic susceptibility mechanism for depression. Nat Neurosci 8:828-834.
38. Pluchino N, Russo M, Santoro AN, Litta P, Cela V, Genazzani AR (2013): Steroid hormones and BDNF. Neuroscience 239:271-279.
39. Price TJ, Cervero F, de Koninck Y (2005): Role of cation-chloride-cotransporters (CCC) in pain and hyperalgesia. Curr Top Med Chem 5:547-555.
40. Protopopescu X, Tuescher O, Pan H, Epstein J, Root J, Chang L, Altemus M, Polanecsky M, McEwen B, Stern E, Silbersweig D (2008): Toward a functional neuroanatomy of premenstrual dysphoric disorder. J Affect Disord 108:87-94.
41. Rauch SL, Shin LM, Phelps EA (2006): Neurocircuitry models of posttraumatic stress disorder and extinction: Human neuroimaging research-Past, present, and future. Biol Psychiatry 60:376-382.
42. Savic I (2010): Sex Differences in the Human Brain, Their Underpinnings and Implications, Vol. 186. Elsevier.
43. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998): The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 (Suppl 20): 22-33;quiz 34-57.
44. Shin LM, Liberzon I (2010): The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 35:169-191.
45. Sladky R, Friston KJ, Trostl J, Cunnington R, Moser E, Windischberger C (2011): Slice-timing effects and their correction in functional MRI. Neuroimage 58:588-594.
46. Sohrabji F, Lewis DK (2006): Estrogen-BDNF interactions: Implications for neurodegenerative diseases. Front Neuroendocrinol 27:404-414.
47. Sohrabji F, Miranda RC, Toran-Allerand CD (1995): Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc Natl Acad Sci USA 92:11110-11114.
48. Soliman F, Glatt CE, Bath KG, Levita L, Jones RM, Pattwell SS, Jing D, Tottenham N, Amso D, Somerville LH, Voss HU, Glover G, Ballon DJ, Liston C, Teslovich T, Van Kempen T, Lee FS, Casey BJ (2010): A genetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science 327:863-866.
49. Spencer JL, Waters EM, Milner TA, Lee FS, McEwen BS (2010): BDNF variant Val66Met interacts with estrous cycle in the control of hippocampal function. Proc Natl Acad Sci USA 107:4395-4400.
50. Sundstrom I, Nyberg S, Bixo M, Hammarback S, Backstrom T (1999): Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen. Acta Obstet Gynecol Scand 78:891-899.
51. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002): Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273-289.
52. Wittchen HU, Becker E, Lieb R, Krause P (2002): Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 32:119-132.
53. Yonkers KA, O'Brien PM, Eriksson E (2008): Premenstrual syndrome. Lancet 371:1200-1210.